Literature DB >> 34319442

Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.

Nelly Joseph-Mathurin1, Namita Sinha2,3, Aihong Zhou4, Nigel J Cairns2,5,6, Tammie L S Benzinger7, Charles D Chen1, Yan Li5, Karl Friedrichsen8, Austin McCullough1, Erin E Franklin2, Russ Hornbeck1, Brian Gordon1, Vijay Sharma1, Carlos Cruchaga9, Alison Goate10, Celeste Karch9, Eric McDade5, Chengjie Xiong5, Randall J Bateman5, Bernardino Ghetti11, John M Ringman12, Jasmeer Chhatwal13, Colin L Masters14, Catriona McLean15, Tammaryn Lashley16,17, Yi Su18,19, Robert Koeppe20, Clifford Jack21, William E Klunk22, John C Morris5, Richard J Perrin2,5.   

Abstract

Pittsburgh compound B (PiB) radiotracer for positron emission tomography (PET) imaging can bind to different types of amyloid-β plaques and blood vessels (cerebral amyloid angiopathy). However, the relative contributions of different plaque subtypes (diffuse versus cored/compact) to in vivo PiB PET signal on a region-by-region basis are incompletely understood. Of particular interest is whether the same staging schemes for summarizing amyloid-β burden are appropriate for both late-onset and autosomal dominant forms of Alzheimer disease (LOAD and ADAD). Here, we compared antemortem PiB PET with follow-up postmortem estimation of amyloid-β burden using stereologic methods to estimate the relative area fraction of diffuse and cored/compact amyloid-β plaques across 16 brain regions in 15 individuals with ADAD and 14 individuals with LOAD. In ADAD, we found that PiB PET correlated with diffuse plaques in the frontal, parietal, temporal, and striatal regions commonly used to summarize amyloid-β burden in PiB PET, and correlated with both diffuse and cored/compact plaques in the occipital lobe and parahippocampal gyrus. In LOAD, we found that PiB PET correlated with both diffuse and cored/compact plaques in the anterior cingulate, frontal lobe (middle frontal gyrus), and parietal lobe, and showed additional correlations with diffuse plaque in the amygdala and occipital lobe, and with cored/compact plaque in the temporal lobe. Thus, commonly used PiB PET summary regions predominantly reflect diffuse plaque burden in ADAD and a mixture of diffuse and cored/compact plaque burden in LOAD. In direct comparisons of ADAD and LOAD, postmortem stereology identified much greater mean amyloid-β plaque burdens in ADAD versus LOAD across almost all brain regions studied. However, standard PiB PET did not recapitulate these stereologic findings, likely due to non-trivial amyloid-β plaque burdens in ADAD within the cerebellum and brainstem-commonly used reference regions in PiB PET. Our findings suggest that PiB PET summary regions correlate with amyloid-β plaque burden in both ADAD and LOAD; however, they might not be reliable in direct comparisons of regional amyloid-β plaque burden between the two forms of AD.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alzheimer disease; Amyloid-β plaques; PiB PET; Stereology

Mesh:

Substances:

Year:  2021        PMID: 34319442      PMCID: PMC8815340          DOI: 10.1007/s00401-021-02342-y

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   15.887


  74 in total

1.  Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

Authors:  William E Klunk; Brian J Lopresti; Milos D Ikonomovic; Iliya M Lefterov; Radosveta P Koldamova; Eric E Abrahamson; Manik L Debnath; Daniel P Holt; Guo-feng Huang; Li Shao; Steven T DeKosky; Julie C Price; Chester A Mathis
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

2.  Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.

Authors:  Michael Schöll; Anders Wall; Steinunn Thordardottir; Daniel Ferreira; Nenad Bogdanovic; Bengt Långström; Ove Almkvist; Caroline Graff; Agneta Nordberg
Journal:  Neurology       Date:  2012-06-13       Impact factor: 9.910

3.  Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar?

Authors:  C A Davies; D M Mann
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

Review 4.  Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.

Authors:  Davis C Ryman; Natalia Acosta-Baena; Paul S Aisen; Thomas Bird; Adrian Danek; Nick C Fox; Alison Goate; Peter Frommelt; Bernardino Ghetti; Jessica B S Langbaum; Francisco Lopera; Ralph Martins; Colin L Masters; Richard P Mayeux; Eric McDade; Sonia Moreno; Eric M Reiman; John M Ringman; Steve Salloway; Peter R Schofield; Reisa Sperling; Pierre N Tariot; Chengjie Xiong; John C Morris; Randall J Bateman
Journal:  Neurology       Date:  2014-06-13       Impact factor: 9.910

5.  Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.

Authors:  Blaine R Roberts; Monica Lind; Aaron Z Wagen; Alan Rembach; Tony Frugier; Qiao-Xin Li; Timothy M Ryan; Catriona A McLean; James D Doecke; Christopher C Rowe; Victor L Villemagne; Colin L Masters
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

6.  Early amyloid-beta deposits show different immunoreactivity to the amino- and carboxy-terminal regions of beta-peptide in Alzheimer's disease and Down's syndrome brain.

Authors:  E Kida; K E Wisniewski; H M Wisniewski
Journal:  Neurosci Lett       Date:  1995-06-30       Impact factor: 3.046

7.  Partial volume correction in quantitative amyloid imaging.

Authors:  Yi Su; Tyler M Blazey; Abraham Z Snyder; Marcus E Raichle; Daniel S Marcus; Beau M Ances; Randall J Bateman; Nigel J Cairns; Patricia Aldea; Lisa Cash; Jon J Christensen; Karl Friedrichsen; Russ C Hornbeck; Angela M Farrar; Christopher J Owen; Richard Mayeux; Adam M Brickman; William Klunk; Julie C Price; Paul M Thompson; Bernadino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Peter R Schofield; Virginia Buckles; John C Morris; Tammie L S Benzinger
Journal:  Neuroimage       Date:  2014-12-05       Impact factor: 6.556

8.  Longitudinal amyloid imaging using 11C-PiB: methodologic considerations.

Authors:  Bart N M van Berckel; Rik Ossenkoppele; Nelleke Tolboom; Maqsood Yaqub; Jessica C Foster-Dingley; Albert D Windhorst; Philip Scheltens; Adriaan A Lammertsma; Ronald Boellaard
Journal:  J Nucl Med       Date:  2013-08-12       Impact factor: 10.057

9.  Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.

Authors:  Randall J Bateman; Paul S Aisen; Bart De Strooper; Nick C Fox; Cynthia A Lemere; John M Ringman; Stephen Salloway; Reisa A Sperling; Manfred Windisch; Chengjie Xiong
Journal:  Alzheimers Res Ther       Date:  2011-01-06       Impact factor: 6.982

10.  Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.

Authors:  Brian A Gordon; Tyler M Blazey; Yi Su; Amrita Hari-Raj; Aylin Dincer; Shaney Flores; Jon Christensen; Eric McDade; Guoqiao Wang; Chengjie Xiong; Nigel J Cairns; Jason Hassenstab; Daniel S Marcus; Anne M Fagan; Clifford R Jack; Russ C Hornbeck; Katrina L Paumier; Beau M Ances; Sarah B Berman; Adam M Brickman; David M Cash; Jasmeer P Chhatwal; Stephen Correia; Stefan Förster; Nick C Fox; Neill R Graff-Radford; Christian la Fougère; Johannes Levin; Colin L Masters; Martin N Rossor; Stephen Salloway; Andrew J Saykin; Peter R Schofield; Paul M Thompson; Michael M Weiner; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Lancet Neurol       Date:  2018-02-01       Impact factor: 44.182

View more
  3 in total

1.  Cryo-EM structures of amyloid-β 42 filaments from human brains.

Authors:  Yang Yang; Diana Arseni; Wenjuan Zhang; Melissa Huang; Sofia Lövestam; Manuel Schweighauser; Abhay Kotecha; Alexey G Murzin; Sew Y Peak-Chew; Jennifer Macdonald; Isabelle Lavenir; Holly J Garringer; Ellen Gelpi; Kathy L Newell; Gabor G Kovacs; Ruben Vidal; Bernardino Ghetti; Benjamin Ryskeldi-Falcon; Sjors H W Scheres; Michel Goedert
Journal:  Science       Date:  2022-01-13       Impact factor: 63.714

Review 2.  Dissecting the clinical heterogeneity of early-onset Alzheimer's disease.

Authors:  Daniel W Sirkis; Luke W Bonham; Taylor P Johnson; Renaud La Joie; Jennifer S Yokoyama
Journal:  Mol Psychiatry       Date:  2022-04-07       Impact factor: 13.437

Review 3.  Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia.

Authors:  Ruiqing Ni; Roger M Nitsch
Journal:  Front Aging Neurosci       Date:  2022-01-03       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.